RA
PHGE icon

Royce & Associates’s BiomX PHGE Stock Holding History

Royce & Associates’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-835
Closed -$54K – 951
2022
Q3 		$54K Sell
835
-895
-52% -$114K ﹤0.01% 919
2022
Q2 		$240K Buy
1,730
+42
+2% +$8.62K ﹤0.01% 901
2022
Q1 		$619K Buy
1,688
+1,126
+200% +$335K 0.01% 857
2021
Q4 		$171K Sell
562
-626
-53% -$250K ﹤0.01% 949
2021
Q3 		$691K Sell
1,188
-701
-37% -$543K 0.01% 861
2021
Q2 		$1.96M Hold
1,889
– – 0.01% 761
2021
Q1 		$2.56M Buy
+1,889
New +$2.55M 0.02% 717

Other funds holding PHGE

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Royce & Associates's PHGE Position: Q4 2022 in Review

Royce & Associates sold out of BiomX (PHGE) in Q4 2022, closing a stake of 835 shares — an estimated $54K sold.

Royce & Associates first reported a position in PHGE in Q1 2021 and held it in 7 quarters. The position peaked at $2.56M in Q1 2021. 13 funds tracked by Wall St. Rank hold PHGE as of Q4 2022.

  • Royce & Associates reported no remaining BiomX position as of Q4 2022 after selling out during the quarter.
  • Royce & Associates sold 835 BiomX shares in Q4 2022, an estimated $54K.
  • Royce & Associates first reported a position in BiomX in Q1 2021 and held it in 7 quarters.
  • Royce & Associates's BiomX position peaked at $2.56M in Q1 2021.
  • 13 funds tracked by Wall St. Rank held BiomX as of Q4 2022.

Based on Royce & Associates's 13F filing for Q4 2022, filed 13 Feb 2023.